Small and Rural
The latest report from AIR340B, a group financed and backed by the pharmaceutical industry, continues to misrepresent a program with a successful 25-year history of helping hospitals stretch scarce financial resources to expand and improve access to lifesaving prescription drugs and comprehensive鈥
Fifty-seven senators Friday urged the Centers for Medicare & Medicaid Services (CMS) to 鈥渃arefully consider stakeholder feedback鈥 before the agency finalizes its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. 鈥淭he long-term success of the鈥
Fifty-seven senators Friday urged the Centers for Medicare & Medicaid Services to 鈥渃arefully consider stakeholder feedback" before the agency finalizes its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. "The long-term success of the 340B鈥
The 340B Drug Pricing Program 鈥渉as enabled hospitals and health systems to support and expand access and services consistent with their mission and the program鈥檚 original and ongoing charge,鈥 the AHA and Association of American Medical Colleges today told leaders of the House Energy and Commerce鈥
The Centers for Medicare & Medicaid Services today officially withdrew its proposal to test new models for how Medicare Part B pays for prescription drugs provided in physician offices and hospital outpatient departments.
Two hundred twenty-eight members of the House of Representatives yesterday urged the Centers for Medicare & Medicaid Services to abandon its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program.
The Health Resources and Services Administration today delayed to July 1, 2018 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers. 鈥淲e are delaying the effective date of the Jan.
A bipartisan group of 228 House lawmakers yesterday urged the Centers for Medicare & Medicaid Services (CMS) to abandon its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program.